Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume.

Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN.

Arch Intern Med. 2009 Jun 22;169(12):1113-21; discussion 1121-2. doi: 10.1001/archinternmed.2009.136. Review.

2.

Placing a price on medical device innovation: the example of total knee arthroplasty.

Suter LG, Paltiel AD, Rome BN, Solomon DH, Thornhill TS, Abrams SK, Katz JN, Losina E.

PLoS One. 2013 May 6;8(5):e62709. doi: 10.1371/journal.pone.0062709. Print 2013.

3.

Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty.

Mather RC 3rd, Hug KT, Orlando LA, Watters TS, Koenig L, Nunley RM, Bolognesi MP.

BMC Musculoskelet Disord. 2014 Jan 18;15:22. doi: 10.1186/1471-2474-15-22.

4.

Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.

Rampersaud YR, Tso P, Walker KR, Lewis SJ, Davey JR, Mahomed NN, Coyte PC.

Spine J. 2014 Feb 1;14(2):244-54. doi: 10.1016/j.spinee.2013.11.011. Epub 2013 Nov 12.

PMID:
24239803
5.

The cost-effectiveness of surgical treatment of medial unicompartmental knee osteoarthritis in younger patients: a computer model-based evaluation.

Konopka JF, Gomoll AH, Thornhill TS, Katz JN, Losina E.

J Bone Joint Surg Am. 2015 May 20;97(10):807-17. doi: 10.2106/JBJS.N.00925.

PMID:
25995491
6.

Economic benefit to society at large of total knee arthroplasty in younger patients: a Markov analysis.

Bedair H, Cha TD, Hansen VJ.

J Bone Joint Surg Am. 2014 Jan 15;96(2):119-26. doi: 10.2106/JBJS.L.01736.

PMID:
24430411
7.

Cost Effectiveness Analysis of Knee Osteoarthritis Treatment.

Stan G, Orban H, Orban C.

Chirurgia (Bucur). 2015 Jul-Aug;110(4):368-74.

8.

Cost-effectiveness of unicondylar versus total knee arthroplasty: a Markov model analysis.

Peersman G, Jak W, Vandenlangenbergh T, Jans C, Cartier P, Fennema P.

Knee. 2014;21 Suppl 1:S37-42. doi: 10.1016/S0968-0160(14)50008-7. Review.

PMID:
25382367
9.

Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient.

Krummenauer F, Wolf C, Günther KP, Kirschner S.

Eur J Med Res. 2009;14:76-84.

10.
11.

Cost-effectiveness and economic impact of the KineSpring ® Knee Implant System in the treatment for knee osteoarthritis.

Li CS, Seeger T, Auhuber TC, Bhandari M.

Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2629-37. doi: 10.1007/s00167-013-2427-x. Epub 2013 Feb 10.

PMID:
23397420
12.

Descriptive analysis of the cost-effectiveness of depressed patients undergoing total knee arthroplasty: an economic decision analysis.

Gong L, Chen H.

J Orthop Sci. 2014 Sep;19(5):820-6. doi: 10.1007/s00776-014-0599-y. Epub 2014 Jul 5.

PMID:
24996623
13.

Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

Losina E, Daigle ME, Suter LG, Hunter DJ, Solomon DH, Walensky RP, Jordan JM, Burbine SA, Paltiel AD, Katz JN.

Osteoarthritis Cartilage. 2013 May;21(5):655-67. doi: 10.1016/j.joca.2013.01.016. Epub 2013 Feb 4.

14.

Impact of hospital volume on the economic value of computer navigation for total knee replacement.

Slover JD, Tosteson AN, Bozic KJ, Rubash HE, Malchau H.

J Bone Joint Surg Am. 2008 Jul;90(7):1492-500. doi: 10.2106/JBJS.G.00888.

15.

Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?

Losina E, Burbine SA, Suter LG, Hunter DJ, Solomon DH, Daigle ME, Dervan EE, Jordan JM, Katz JN.

Osteoarthritis Cartilage. 2014 Mar;22(3):415-30. doi: 10.1016/j.joca.2014.01.005. Epub 2014 Jan 31.

16.

The direct and indirect costs to society of treatment for end-stage knee osteoarthritis.

Ruiz D Jr, Koenig L, Dall TM, Gallo P, Narzikul A, Parvizi J, Tongue J.

J Bone Joint Surg Am. 2013 Aug 21;95(16):1473-80. doi: 10.2106/JBJS.L.01488.

PMID:
23965697
17.

Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.

Losina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, Klara K, Suter LG, Solomon DH, Burbine SA, Walensky RP, Katz JN.

Arthritis Care Res (Hoboken). 2015 Feb;67(2):203-15. doi: 10.1002/acr.22412.

18.

A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.

Chang RW, Pellisier JM, Hazen GB.

JAMA. 1996 Mar 20;275(11):858-65.

PMID:
8596224
19.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

Haentjens P, De Groote K, Annemans L.

Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.

PMID:
15365714
20.

Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database.

Singh JA, Kwoh CK, Boudreau RM, Lee GC, Ibrahim SA.

Arthritis Rheum. 2011 Aug;63(8):2531-9. doi: 10.1002/art.30390.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk